Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles

Paclitaxel (PTX) is frequently suffered from multidrug resistance (MDR), resulting in lower chemotherapeutic efficacy and even chemotherapy failure. To combine the P-glycolprotein (P-gp) inhibitor would be a useful strategy to overcome MDR. However, what is needed now is an efficient vehicle to deli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Liang, Wang, Di, Hu, Yichen, Fu, Chaomei, Li, Wei, Dai, Liping, Yang, Lin, Zhang, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601152/
https://www.ncbi.nlm.nih.gov/pubmed/28947984
http://dx.doi.org/10.18632/oncotarget.19728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601152/
https://www.ncbi.nlm.nih.gov/pubmed/28947984
http://dx.doi.org/10.18632/oncotarget.19728

Ejemplares similares